At this year's conference, Alliance investigators will present more than 20 abstracts, sharing the latest findings on breast cancer, rare cancer, blood and bone cancer, GI and GU cancers, along with cancer control research

The ECOG-ACRIN Cancer Research Group announces the recipients of the organization’s annual scientific leadership and mentorship awards

Drs. Dawn Hershman and Primo Lara elected group co-chairs-elect of SWOG Cancer Research Network

The International Penile Advanced Cancer Trial (InPACT) has just recruited its 100th patient—a historic achievement

The Alliance Board of Directors has elected Evanthia Galanis, MD, as Group Chair-Elect of the Alliance for Clinical Trials in Oncology; she will take office in November and will serve a six-year term

The POSITIVE international clinical trial found that for young women with hormone receptor-positive breast cancer, pausing endocrine therapy to pursue a pregnancy did not raise the short-term risk that the disease will recur

The patient-reported outcomes of the RTOG 0815 clinical trial comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT combined with short-term (6 months) androgen deprivation therapy (STAD) indicate that the addition of STAD did not significantly impact urinary or bowel quality of life but did significantly decrease hormone and sexual quality of life

Results from the RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term androgen deprivation (STAD) did not meet its primary endpoint of improving overall survival for men with intermediate-risk prostate cancer through the addition of STAD

Results from the RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the spine did not meet its primary endpoint